KOWA COMPANY, LTD. (E02819)

Market cap
P/E ratio
Kowa develops and sells prescription and over-the-counter medicines including popular nutritional drinks and cold remedies, while also operating trading, optical equipment, and hospitality businesses across 117 global subsidiaries.
Period EndProceeds from issuance of term debt, net (Million JPY)YoY (%)
Mar 31, 202360,695+16.30%
Mar 31, 202252,190-19.86%
Mar 31, 202165,120+161.16%
Mar 31, 202024,935-64.33%
Mar 31, 201969,900+191.09%
Mar 31, 201824,013-19.39%
Mar 31, 201729,790+72.15%
Mar 31, 201617,305-53.05%
Mar 31, 201536,856-2.63%
Mar 31, 201437,852-10.87%
Mar 31, 201342,466
AI Chat